Alana McNulty
2021
In 2021, Alana McNulty earned a total compensation of $1.7M as Chief Business Officer at eFFECTOR Therapeutics, a 198% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $128,000 |
|---|---|
| Salary | $383,814 |
| Stock Awards | $1,168,270 |
| Other | $30,264 |
| Total | $1,710,348 |
McNulty received $1.2M in stock awards, accounting for 68% of the total pay in 2021.
McNulty also received $128K in non-equity incentive plan, $383.8K in salary and $30.3K in other compensation.
Rankings
In 2021, Alana McNulty's compensation ranked 6,691st out of 12,415 executives tracked by ExecPay. In other words, McNulty earned more than 46.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,691 out of 12,415 | 46th |
Division Manufacturing | 2,898 out of 5,508 | 47th |
Major group Chemicals And Allied Products | 1,274 out of 2,378 | 46th |
Industry group Drugs | 1,136 out of 2,099 | 46th |
Industry Pharmaceutical Preparations | 826 out of 1,549 | 47th |
Source: SEC filing on April 20, 2022.
McNulty's colleagues
We found three more compensation records of executives who worked with Alana McNulty at eFFECTOR Therapeutics in 2021.